Drug-Device Combination Products Consultant in Pune
Pune is a rapidly growing hub for the medical device industry in India, with a focus on research and development, and manufacturing of high-end products such as orthopedic implants, medical electronics, and advanced surgical instruments. The industry is supported by a favorable business environment, skilled workforce, and a growing network of research institutions and healthcare facilities, making it an attractive destination for investment.
Combination products are a unique category of medical products that combine two or more regulated components, including drugs, devices, and biological products. As a Drug Device Combination Products Consultant in Pune, we provide comprehensive guidance on combination products under 21 CFR 3.2 (e).
Types of Drug-Device Combination Products
- Pre-filled syringes
- Drug-eluting stents
- Inhalers
- Transdermal patches
- Implantable drug delivery systems
- Drug-device combination products for diagnostics
- Drug-device combination products for drug delivery systems
- Drug-device combination products for gene therapy
Drug-Device Combination Products Consultant in Pune?
Let’s have word about your next project
Benefits of Drug-Drug Combination Products
Despite the challenges, drug-device combination products offer many unique benefits over traditional drugs or devices alone, such as targeted therapy, improved drug delivery, and increased patient compliance. They represent an exciting and growing area of innovation in the healthcare industry, with the potential to improve patient outcomes and quality of life.
If you are looking for expert guidance in the development and regulation of drug-device combination products in Pune, Operon Strategist can help. Our team of experienced consultants offers a range of services. Contact us today to learn more.
FAQs
What is a drug-device combination product?
A drug-device combination product is a medical product that combines two or more regulated components—such as a drug and a device—into a single entity. Examples include pre-filled syringes, drug-eluting stents, inhalers, and transdermal patches.
Which regulations apply to drug-device combination products?
Combination products are regulated under 21 CFR Part 3.2(e) in the United States. Depending on the primary mode of action (PMOA), they may require compliance with drug (CDER), device (CDRH), or biologics (CBER) regulatory pathways.
How can a consultant help manufacturers in Pune?
A consultant provides regulatory classification support, submission strategy (IND, NDA, ANDA, 510(k), PMA), quality system alignment (21 CFR Part 820 & 210/211), risk management documentation, and global market access planning.
What are the key challenges in developing combination products?
Major challenges include determining the primary mode of action, coordinating multiple regulatory requirements, integrating drug and device quality systems, conducting stability and performance studies, and managing post-market surveillance.
What are the benefits of drug-device combination products?
They offer targeted drug delivery, improved therapeutic effectiveness, reduced dosing frequency, enhanced patient compliance, and better overall treatment outcomes.